Skip to main content
. 2014 Mar 15;15:72. doi: 10.1186/1471-2105-15-72

Table 5.

Distances (Å) between the amino acid of the protease and the PI heteroatoms

 
 
Protease
 
aa/Chain-PIs  
Protease
 
aa/Chain-PIs Wild type Resistant Emergent Wild type Resistant Emergent
PR-IDV
[2R5P]
[1K6C]
D29V
PR-LPV
[2Q5K]
[1RV7]
D29V
29/A-N2
6.1
6.1
5.4
25/A-O4
5.4
6.8
9.1
29/B-O4
3.9
4.2
4.8
25/B-O4
5.5
7.8
9.9
30/A-N2
6.5
6.6
6.3
29/A-O1
5.8
10.8
6
30/B-O4
6.3
6.4
7
29/B-O3
6
10.3
5.3
82/A-O2
10.1
10.7
11.2
30/A-O1
3.7
9.8
7.1
82/B-N1
6.1
6.2
7.5
30/B-O3
6.7
10.1
5.3
84/A-O2
8.3
8.2
9.3
84/A-O4
8.2
10.1
10.4
84/B-N1
7.9
7.9
8.4
84/B-O3
7.6
8.1
8.2
PR-SQV
[3OXC]
[3CYW]
D29V
PR-RTV
[3NDX]
[1RL8]
D29V
29/A-OD1
4.1
5.3
3.5
29/A-O76
4
3.8
4.9
29/B-N3
6.1
6
7.5
29/B-N5
5.6
4
5.1
30/A-OD1
3.8
4.2
3.8
30/A-O76
6.1
6.1
6.9
30/B-N3
6.5
6.4
7.5
30/B-S3
4
5.5
8.8
48/A-ND2
3.4
5.6
7.9
82/A-N11
9.4
9.5
9.6
48/B-N3
4
6.3
6.3
82/B-O7
10.5
10.3
11.6
PR-APV
[3NU3]
[3NU4]
D29V
PR-DRV
[IT3R]
[2HS1]
D29V
29/A-O6
4.5
4.2
4
29/A-O26
3.9
4.1
10.4
29/B-N3
4.3
4.6
7.6
29/B-N1
4.6
4.4
7.3
30/A-O6
4.5
3.8
3.8
30/A-O26
3.8
3.8
12.3
30/B-N3
3.3
3.7
10.7
30/B-N1
3.8
3.7
9.5
32/A-O6
6.6
6.6
6.9
32/A-O26
7.2
7.5
13.9
32/B-N3
6.3
6.3
15
32/B-N1
6.1
7.6
13.3
PR-TPV
[2O4P]
[1DS4]
D29V
PR-ATV
[3EKY]
[3OXX]
D29V
29/A-N28
6.1
6.2
9.6
29/A-OAI
3.9
5.1
5.6
29/B-O1
9.1
9.4
8.4
29/B-OAJ
3.9
4
8.3
30/A-N28
6.2
6
8.7
30/A-OAI
6.1
6
8.7
30/B-O1
10
10.2
8.6
30/B-OAJ
6
6
8.5
82/A-O8
10.7
10
10.2
50/A-O1
5.7
5.6
4.8
82/B-O7
10.3
9.9
7.7
50/B-O1
5.3
5.4
3.6
84/A-O8
8.3
8.1
8.5
 
 
 
 
84/B-O8
8.4
7.8
8.1
 
 
 
 
PR-NFV
[3EKX]
[2PYM]
D29V
 
 
 
 
29/A-N12
5.9
6.3
5.8
 
 
 
 
29/B-O38
5
4.4
3.8
 
 
 
 
30/A-N12
6.4
6.7
6.3
 
 
 
 
30/B-O38 3.9 3.7 3.7        

The classification of atoms corresponds to the PDB file visualized in PyMOL. Measurements correspond to the distance between the alpha carbon of the PR amino acids and the heteroatoms of the inhibitor, and are expressed as number of amino acids/chain PR − PI heteroatom.

PIs, protease inhibitors; aa, amino acid; PR, protease; APV, amprenavir; ATV, atazanavir; DRV, darunavir; IDV, indinavir; LPV, lopinavir; RTV, ritonavir; SQV, saquinavir; TPV, tipranavir.